4CPS-033 Real-world treatment patterns and outcomes of selective cyclin-dependent kinase (CDK) 4/6 inhibitors utilisation in metastatic breast cancer – REVEAL study

Cruz, JP ; Pereira, L ; Santos, JB ; Castanha, A ; Rodrigues, AC ; Costa, I ; Varela, C ; Dimas, F ; Araújo, A ; Andreozzi, V ; Félix, J

European journal of hospital pharmacy. Science and practice, 2024-03, Vol.31 (Suppl 1), p.A66-A67 [Periódico revisado por pares]

London: British Medical Journal Publishing Group

Texto completo disponível